Down-regulatory effect of Mycobacterium leprae cell wall lipids on phagocytosis, oxidative respiratory burst and tumour cell killing by mouse bone marrow derived macrophages

Scandinavian Journal of Immunology

Volumn 46, Issue 5, 1997, Pages 500-505

  Moura, A C N ^a   Modolell, M ^b   Mariano, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL VIRULENCE; CYTOLYSIS; DOWN REGULATION; IMMUNOREGULATION; LIPID COMPOSITION; MACROPHAGE ACTIVATION; MALE; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0030722016     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-158.x     Document Type: Article

References (39)

1. Rook GAW. Progress in the immunology of the mycobacteriosis. Clin Exp Immunol 1987;69:1-9.
2. Silva CL, Ekizlerian SM, Fazioli RA. Role of cord factor in the modulation of infection caused by Mycobacteria. Am J Pathol 1985;118:238-47.
3. Castells RA, Ramirez BA, Holzmann H, de las Águas JTT. Immunology of leprosy. Review of data from the 1980-90 time period. Hautarzt 1992;43:184-9.
4. Desai SD, Birdi TJ, Antia NH. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals. Infect Immun 1989;57:1311-17.
5. Holzer TJ, Kislaitis L, Vachula M Weaver CW, Andersen BR. Human phagocytic cell responses to Mycobacterium leprae and M. bovis BCG: an in vitro comparison of leprosy vaccine components. J Immunol 1988;141:1701-8.
6. Nunzi E, Leiker DL. Manuale de Leprologia. Bologna, o. c. s. i. 1990.
7. Campbell G, Cree IA. Macrophage and epithelioid cell nuclear morphology in leprosy. Pathol Res Pract 1992;188:625-9.
8. Rastogi N, Frehel C. Evidence that coating of Mycobacterium leprae surface antigen reduces its ability to hinder host microbicidal functions. Zentralbl Backteriol 1990;272:337-46.
9. Damle A, Mahadevan PR. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice. Indian J Lepr 1993;65:271-8.
10. Harris EB, Franzblau SG, Hastings RC. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity. Int J Lepr 1988;56:588-91.
11. Melancon-Kaplan J, Hunter SW, McNeil M et al. Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci USA 1988;85:1917-21.
12. Moura ACN, Mariano M. Dead Mycobacterium leprae inhibits phagocytosis by inflammatory macrophages in vivo. Participation of the bacteria cell wall lipids in the phenomenon. Mem Inst Oswaldo Cruz, Rio de Janeiro 1990;85:381-2.
13. Moura ACN, Mariano M. Lipids from Mycobacterium leprae cell wall are endowed with an antiinflammatory property and inhibit macrophage function 'in vivo'. Immunology 1996;89:613-18.
14. Moura ACN, Werneck-Barroso E, Sampaio ALF, Cordeiro RSB, Henriques MGMO. Mycobacterium leprae and Mycobacterium bovis - BCG evoke distinct inflammatory response in mice pleurisy. Inflammation Res 1995;44:288.
15. Appelberg R, Scares R, Ferreira P, Silva MT. Induction of nonspecific immuno-suppression in mice by mycobacterial infections and its relationship to macrophage activation. Scand J Immunol 1989;30:165-74.
16. Birdi TJ, Antia NH. The macrophage in leprosy: a review on the current status. Int J Lepr 1989;57:511-25.
17. Flesh I, Kaufmann SHE. Mycobacterial growth inhibition by IFNγ activated bone marrow macrophage and differential susceptibility among strains of M. tuberculosis. J Immunol 1987;138:4408-13.
18. Hunter SW, Brennan PJ. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in mitogenicity and pathogenicity. J Bacteriol 1981;147:728-35.
19. Launois P, Blum L, Dieye A, Milan J, Sarthou JL. Phenolic glycolipid-1 from Mycobacterium leprae inhibits oxygen free-radical production by human mononuclear cells. Res Immunol 1989;140:847-55.
20. Marolia J, Mahadevan PR. Reactive oxygen intermediates inactive Mycobacterium leprae in the phagocytes from human peripheral blood. Int J Lepr 1989;57:483-91.
21. Schlesinger LS, Horwitz MA. Phenolyc glycolipid-1 of Mycobacterium leprae binds complement C3 in serum and mediates phagocytosis by human monocytes. J Exp Med 1991;174:1031-8.
22. Sibley LD, Krahenbuhl JL. Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae. Infect Immun 1988;56:1912-19.
23. Sibley LD, Franzblau SG, Krahenbuhl JL. Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages. Infect Immun 1987;55:680-95.
24. Bloch H. Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms. J Exp Med 1950;91:197-217.
25. Bangham AD, Hill MW, Miller NG. Preparation and use of liposomes as models of biological membranes. In: Korn ED. ed. Methods of Membrane Biology, Vol. 1. Oxford: Plenum Press, 1974:68.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Studier FW. Analysis of bacteriophage T7 Y RNAs and proteins on slab gels. J Mol Biol 1973;79:237-48.
28. Munder PG, Modollel M, Wallach DFH. Alkyllysophospholipids in tumoricidal macrophage ability. FEBS Lett 1971;15:191-2.
29. Damoiseaux JGMC, Döpp EA, Beelen RHJ, Dijkstra CD. Rat bone marrow and monocyte cultures: influence of culture time and lymphokines on the expression of macrophage differentiation antigens. J Leukocyte Biol 1989;46:246-53.
30. Mariano M, Nikitin T, Malucelli BE. Immunological and non-immunological phagocytosis by inflammatory macrophages, epithelioid cells and macrophage polykaryons from foreign body granulomata. J Pathol 1976;120:151-9.
31. Klebanoff SS. Phagocytic cell: products of oxygen metabolism in inflammation. In: Callin JL, Goldstein IM, Syderman R, eds. Basic Principles and Clinical Correlates. New York: Raven Press, 1988:391-444.
32. Modolell M, Munder PG. Macrophage mediated tumor cell destruction measured by an alkaline phosphatase assay. J Immunol Methods 1994;174:203-6.
33. Mossmann TM. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol 1983;65:55-63.
34. Zhang L, Goren MB, Holzer TJ, Andersen BR. Effect of Mycobacterium tuberculosis sulfolipid I on human phagocytic cells. Infect Immun 1988;56:2876-83.
35. Pabst MJ, Gross JM, Drozna JP, Goren MB. Inhibition of macrophage priming by sulfatide from Mycobucterium tuberculosis. J Immunol 1988;140:634-40.
36. Mariano M. The experimental granuloma. A hypothesis to explain the persistence of the lesion. Rev Inst Med Trop, São Paulo 1995;37:161-70.
37. Moura ACN, Mariano M. Lipids from Mycobacterium leprae cell wall suppress T cell activation in vivo and in vitro. Immunology 1997; in press.
38. Bloom BR. Leprosy. A molecular and immunological approach.In: England PT, Sher A, eds. The Biology of Parasitism. New York: Alan R. Liss, 1988:265-84.
39. Leyva-Cobian F, Unanue ER. Intracellular interference with antigen presentation. J Immunol 1988;141:1445-50.